go-v.orgdoi

Reversal of Platinum-based Chemotherapy Resistance in Ovarian Cancer by Naringin Through Modulation of The Gut Microbiota in a Humanized Nude Mouse Model

Bingqing Xie, Xiaoni Zhou, Chuanlin Luo, Yilin Fang, Yufei Wang, Jing Wei, Liping Cai, Tingtao Chen · Journal of Cancer · 2024

  • DOI 10.7150/jca.96448
  • Publisher Ivyspring International Publisher
  • Type article
  • Issued 2024

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Journal of Cancer · Ivyspring International Publisher · article · 2024

Abstract

As a chemotherapy agent, cisplatin (DDP) is often associated with drug resistance and gastrointestinal toxicity, factors that severely limit therapeutic efficacy in patients with ovarian cancer (OC).Naringin has been shown to increase sensitivity to cisplatin, but whether the intestinal microbiota is associated with this effect has not been reported so far.In this study, we applied a humanized mouse model for the first time to evaluate the reversal of cisplatin resistance by naringin, as well as naringin combined with the microbiota in ovarian cancer.The results showed that naringin combined with Bifidobacterium animalis subsp.lactis NCU-01 had an inhibitory effect on the tumor, significantly reducing tumor size (p<0.05),as well as the concentrations of serum tumor markers CA125 and HE4, increased the relative abundance of Bifidobacterium and Bacteroides, inhibit Toll-like receptor 4 (TLR4)/nuclear factor κB (NF-κB)-induced intestinal inflammation and increase the expression of intestinal permeability-associated proteins ZO-1 (p<0.001) and occludin (p<0.01).In conclusion, the above data demonstrate how naringin combined with Bifidobacterium animalis subsp.lactis NCU-01 reverses cisplatin resistance in ovarian cancer by modulating the intestinal microbiota, inhibiting the TLR4/NF-κB signaling pathway and modulating the p38MAPK signaling pathway.

Open the resolved locator · 10.7150/jca.96448

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-20 03:59 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://www.jcancer.org/v15p4430.htm
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.